OF HIV INFECTION

Following US Food and Drugs Administration approval in July 2012 of daily oral tenofovir and emtricitabine for pre-exposure prophylaxis (PrEP) to prevent HIV infection in

Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for

Guidance on Pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men who have sex with men and transgender women at high risk of HIV in..

High incidence and prevalence of sexually transmitted infections (STIs) in HIV pre-exposure prophylaxis (PrEP) users: systematic review and analysis.. (Manuscript

Moreover, selecting specific sites and facilities at which PrEP will be offered requires an understanding of where people at substantial risk for HIV infection go for health

People who received oral PrEP at least once includes those who initiated PrEP for the first time and those who may have discontinued PrEP and restarted PrEP in the reporting

As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those

Recommendation: Voluntary medical male circumcision (VMMC) should continue to be promoted as an additional efficacious HIV prevention option within combination prevention